연구성과로 돌아가기

2023 연구자 정보 (48 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Khan, Nawazish
(Khan, N) ⓘ 		Aptose Biosci, San Diego, CA USA ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Tuspetinib Myeloid Kinase Inhibitor Safety and Efficacy As Monotherapy and Combined with Venetoclax in Phase 1/2 Trial of Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) ⓘ SCIE ⓘ 1.5 HEMATOLOGY ⓘ ⓘ
Kim, Byoung Joon
(Kim, BJ) ⓘ 		교신저자 Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurol, Sch Med, Seoul, South Korea
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum ⓘ 		SCIE ⓘ 1.5 CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY
CLINICAL NEUROLOGY;NEUROSCIENCES ⓘ 		bjkim@skku.edu;sueh916@gmail.com; ⓘ
Kim, C. H.
(Kim, CH) ⓘ 		Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea
Hanyang Univ, Dept Phys, Seoul 04763, South Korea
Hanyang Univ, Inst Nat Sci, Seoul 04763, South Korea ⓘ 		AAB-4602-2022
Kim, Ji Hoon ⓘ
ⓘ 		[JCR상위 1.5] Comparison of etoposide/cisplatin and irinotecan/cisplatin for extensive-stage small cell lung cancer in Koreans: A real-world retrospective observational study
[JCR상위 19.6] Search for the decay B⁰ → K*⁰τ⁺τ⁻ at the Belle experiment ⓘ 		SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM
ASTRONOMY & ASTROPHYSICS;PHYSICS, PARTICLES & FIELDS ⓘ 		ⓘ
Kim, C. R.
(Kim, CR) ⓘ 		Seoul Natl Univ, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] EGFR Exon 20 Insertion Mutations in NSCLC: The Need for Accurate Naming Conventions and Implications for Personalized Therapy ⓘ SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM ⓘ ⓘ
Kim, Dennis D. H.
(Kim, DDH) ⓘ 		Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada ⓘ AAH-8499-2019
Kim, Dennis ⓘ
ⓘ 		[JCR상위 1.5] The Co-Occurrence of bZIP in-Frame CEBPA-Mutation with Unfavorable Genetic Abnormalities Is Associated with a Poor Prognosis in Acute Myeloid Leukemia ⓘ SCIE ⓘ 1.5 HEMATOLOGY ⓘ ⓘ
Kim, Hakyoung
(Kim, H) ⓘ 		Korea Univ, Coll Med, Dept Radiat Oncol, Guro Hosp, Seoul, South Korea
Dongguk Univ, Ilsan Hosp, Coll Med, Dept Surg, Goyang, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR
[JCR상위 3.5] Survival Outcomes in Premenopausal Patients With Invasive Lobular Carcinoma ⓘ 		SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM
MEDICINE, GENERAL & INTERNAL ⓘ 		droij@jnu.ac.kr;
haapybirth@amc.seoul.kr; ⓘ
Kim, Heeje
(Kim, H) ⓘ 		Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Hematol, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] The Co-Occurrence of bZIP in-Frame CEBPA-Mutation with Unfavorable Genetic Abnormalities Is Associated with a Poor Prognosis in Acute Myeloid Leukemia ⓘ SCIE ⓘ 1.5 HEMATOLOGY ⓘ ⓘ
Kim, Hyeoung Joon
(Kim, HJ) ⓘ 		Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Hwasun, South Korea
Chonnam Natl Univ, Hwasun Hosp, Genom Res Ctr Hematopoiet Dis, Hawsun, Jeollanam Do, South Korea ⓘ 		IAP-6721-2023
Kim, Chang Gon ⓘ
ⓘ 		[JCR상위 1.5] The Co-Occurrence of bZIP in-Frame CEBPA-Mutation with Unfavorable Genetic Abnormalities Is Associated with a Poor Prognosis in Acute Myeloid Leukemia ⓘ SCIE ⓘ 1.5 HEMATOLOGY ⓘ ⓘ
Kim, Jun-Soon
(Kim, JS) ⓘ 		Seoul Natl Univ, Dept Neurol, Bundang Hosp, Seongnam, South Korea
Seoul Natl Univ, Bundang Hosp, Dept Neurol, Bundang, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum ⓘ 		SCIE ⓘ 1.5 CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY
CLINICAL NEUROLOGY;NEUROSCIENCES ⓘ 		bjkim@skku.edu;sueh916@gmail.com; ⓘ
Kim, Sunyoung
(Kim, S) ⓘ 		교신저자 Ulsan Univ Hosp, Dept Neurol, Coll Med, Ulsan, South Korea
Ulsan Univ Hosp, Coll Med, Dept Neurol, Ulsan, South Korea
Univ Ulsan, Dept Neurol, Coll Med, Ulsan, South Korea ⓘ 		B-9921-2013
Kim, Tae ⓘ 		0000-0003-1333-6147
Kim, Sunyoung ⓘ 		[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis ⓘ 		SCIE ⓘ 1.5 CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY
CLINICAL NEUROLOGY;NEUROSCIENCES
CLINICAL NEUROLOGY ⓘ 		bjkim@skku.edu;sueh916@gmail.com;
paddy.waters@ndcn.ox.ac.uk;nrhong@gmail.com; ⓘ
Kim, Y. -C.
(Kim, YC) ⓘ 		Chonnam Natl Univ, Sch Med, Jeonnam, South Korea
Hwasun Hosp, Jeonnam, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy ⓘ SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM ⓘ ⓘ
Kim, Y. -H.
(Kim, YH) ⓘ 		Chonnam Natl Univ, Sch Med, Jeonnam, South Korea
Hwasun Hosp, Jeonnam, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy ⓘ SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM ⓘ ⓘ
Kim, Yong-Hyub
(Kim, YH) ⓘ 		Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea
Chonnam Natl Univ, Med Sch, Dept Radiat Oncol, Hwasun, Jeonnam, South Korea ⓘ 		AAK-1840-2021
Kim, Yong-Joo ⓘ
ⓘ 		[JCR상위 1.5] Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR ⓘ SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM ⓘ droij@jnu.ac.kr; ⓘ
Koller, Paul B.
(Koller, PB) ⓘ 		City Hope Natl Med Ctr, Hematol HCT, Duarte, CA USA ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] Tuspetinib Myeloid Kinase Inhibitor Safety and Efficacy As Monotherapy and Combined with Venetoclax in Phase 1/2 Trial of Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) ⓘ SCIE ⓘ 1.5 HEMATOLOGY ⓘ ⓘ
Kwon, M. J.
(Kwon, MJ) ⓘ 		Kyungpook Natl Univ, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.5] EGFR Exon 20 Insertion Mutations in NSCLC: The Need for Accurate Naming Conventions and Implications for Personalized Therapy ⓘ SCIE ⓘ 1.5 ONCOLOGY;RESPIRATORY SYSTEM ⓘ ⓘ
페이지 이동: